Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (121-130 of 188) with videos related to

Pageof 19
Sort By:
The Journal of Antimicrobial Chemotherapy|December 13, 2018
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
HIV Clinical Trials|May 18, 2018
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemiaLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
Infection|November 13, 2019
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavirLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
International Journal of STD & AIDS|April 2, 2026
Changing epidemiology and clinical presentation of rectal lymphogranuloma venereum in the HIV-PrEP era: A comparative study from Bologna, ItalyValeria Gaspari, Leonardo Calza, Simone Ambretti, et al.
Infectious Diseases (London, England)|July 8, 2017
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected PatientsLeonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2012
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancyLeonardo Calza, Roberto Manfredi, Filippo Trapani, et al.
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Pageof 19

Showing results (121-130 of 188) with videos related to

Sort By:
Pageof 19
The Journal of Antimicrobial Chemotherapy|December 13, 2018
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
HIV Clinical Trials|May 18, 2018
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemiaLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
Infection|November 13, 2019
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavirLeonardo Calza, Vincenzo Colangeli, Marco Borderi, et al.
International Journal of STD & AIDS|April 2, 2026
Changing epidemiology and clinical presentation of rectal lymphogranuloma venereum in the HIV-PrEP era: A comparative study from Bologna, ItalyValeria Gaspari, Leonardo Calza, Simone Ambretti, et al.
Infectious Diseases (London, England)|July 8, 2017
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Dual Raltegravir-Etravirine Combination as Maintenance Regimen in Virologically Suppressed HIV-1-Infected PatientsLeonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
Scandinavian Journal of Infectious Diseases|January 24, 2012
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancyLeonardo Calza, Roberto Manfredi, Filippo Trapani, et al.
HIV Clinical Trials|May 18, 2012
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitorsLeonardo Calza, Filippo Trapani, Michele Bartoletti, et al.
Pageof 19